IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 144 filers reported holding IMMUNITYBIO INC in Q4 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $443,794 | -39.2% | 262,600 | 0.0% | 0.01% | -42.9% |
| Q2 2023 | $730,028 | +307.6% | 262,600 | +166.9% | 0.01% | +250.0% |
| Q1 2023 | $179,088 | -64.1% | 98,400 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $498,888 | +1.8% | 98,400 | 0.0% | 0.01% | +33.3% |
| Q3 2022 | $490,000 | -73.7% | 98,400 | -67.9% | 0.01% | -62.5% |
| Q4 2021 | $1,864,000 | -38.5% | 306,600 | -1.5% | 0.02% | -36.0% |
| Q3 2021 | $3,033,000 | -31.8% | 311,400 | 0.0% | 0.02% | -21.9% |
| Q2 2021 | $4,447,000 | -40.8% | 311,400 | -1.5% | 0.03% | -48.4% |
| Q1 2021 | $7,506,000 | – | 316,200 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 251,556 | $1,387,000 | 1.70% |
| ORACLE INVESTMENT MANAGEMENT INC | 315,322 | $1,567,000 | 0.89% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,668,000 | 0.54% |
| ALLEN HOLDING INC /NY | 687,571 | $3,417,000 | 0.54% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $479,000 | 0.21% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $1,033,000 | 0.17% |
| Clearwater Capital Advisors, LLC | 185,911 | $924,000 | 0.13% |
| WEALTH EFFECTS LLC | 28,500 | $142,000 | 0.09% |
| Virtus ETF Advisers LLC | 35,048 | $174,000 | 0.07% |
| Vident Investment Advisory, LLC | 195,127 | $969,000 | 0.03% |